| 000 | 018420000a22003850004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223030526.0 | ||
| 008 | 081006s2006 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.03.Ph.D.2006.Ne.S. | ||
| 100 | 0 | _aNevine Mohamed Fathy Alazhary | |
| 245 | 1 | 0 |
_aStudy of selected apoptotic markers and adhesion molecules in Chronic Lymphocytic Leukemia / _cNevine Mohamed Fathy Alazhary ; Supervised Amira Mokhtar Khorshed , Hisham Mahmoud Hafez Shahin , Thuraya Mohamed Abd El hamid |
| 246 | 1 | 5 | _aدراسة بعض دلالات الموت المبرمج للخلايا وبعض جزئيات التلاصق فى حالات سرطان الدم الليمفاوى المزمن |
| 260 |
_aCairo : _bNevine Mohamed Fathy Alazhary , _c2006 |
||
| 300 |
_a161P : _bdiagrs ; _c25cm |
||
| 502 | _aThesis (PH.D.) - Cairo University - National Cancer Institute - Department Of Clinical Pathology | ||
| 520 | _aB - cell chronic lymphocytic leukemia (B - CLL) cannot be cured with conventional chemotherapy and this appears to be at least partially due to the fact that B - CLL cells are resistant to both apoptosis , and to entry in the cell cycleMany internal and external external factors affect maintenance survival of leukemia cells | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBel - 2 | |
| 653 | 4 | _aCD18 and CD54 | |
| 653 | 4 | _aCD95 and adhesion | |
| 653 | 4 | _aCLL | |
| 653 | 4 | _ap53 | |
| 653 | 4 | _aPrognosis | |
| 700 | 0 |
_aAmira Mokhtar Khorshed , _eSupervisor |
|
| 700 | 0 |
_aHisham Mahmoud Hafez Shahin , _eSupervisor |
|
| 700 | 0 |
_aThuraya Mohamed Abd El hamid , _esupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c36555 _d36555 |
||